Take Your Trading To The Next Level. Get Started Here!
+1 (949) 514 8188
The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with schizophrenia.
FDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades
The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with schizophrenia.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender